Literature DB >> 4111430

Three cases of multiple myeloma in which the preclinical asymptomatic phases persisted throughout 15 to 24 years.

O Norgaard.   

Abstract

During the period from 1950 to 1952, three patients were studied by electrophoresis according to Tiselius on account of anticomplementary activity at WR; the presence of an M-component was demonstrated. On several later occasions it was observed that this component at first seemed to remain unchanged, later it was slightly increased; repeated examinations did not give evidence of multiple myeloma. At intervals ranging from 15 to 24 years after the primary demonstration of the M-component, all three patients presented with symptoms of multiple myeloma and died within less than one year after the disease had been diagnosed. The following conclusions are drawn:(1) The preclinical phase of multiple myeloma may cover up to 24 years.(2) A presence of multiple myeloma cannot be precluded, even after follow-up throughout 24 years, in cases of the so-called "benign monoclonal gammopathy".

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4111430      PMCID: PMC2008754          DOI: 10.1038/bjc.1971.53

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  4 in total

1.  MEGALOBLASTIC ANAEMIA AND MYXOEDEMA IN A PATIENT SUFFERING FROM MYELOMA, OBSERVED FOR A PERIOD OF 16 YEARS.

Authors:  J BICHEL
Journal:  Acta Med Scand       Date:  1964-08

2.  Detection and diagnosis of monoclonal gammopathy.

Authors:  C A Sleeper; L P Cawley
Journal:  Am J Clin Pathol       Date:  1969-03       Impact factor: 2.493

3.  Paraproteins.

Authors:  J R Hobbs
Journal:  Proc R Soc Med       Date:  1969-08

4.  Immunoglobulin synthesis and total body tumor cell number in IgG multiple myeloma.

Authors:  S E Salmon; B A Smith
Journal:  J Clin Invest       Date:  1970-06       Impact factor: 14.808

  4 in total
  5 in total

1.  [The beginning plasmacytoma].

Authors:  H Brücher
Journal:  Blut       Date:  1974-02

2.  Lymphocyte subsets in the peripheral blood of patients with multiple myeloma and benign monoclonal gammopathy.

Authors:  F Herrmann; A Lochner; B Jauer; G Sieber; H Rühl
Journal:  Klin Wochenschr       Date:  1983-08-15

Review 3.  Protein analyses in myelomatosis.

Authors:  P M Carter; L Slater; J Lee; D Perry; J R Hobbs
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1975

4.  Increased frequency of monoclonal gammopathy of undetermined significance in patients with nonimmune chronic idiopathic neutropenia syndrome.

Authors:  H A Papadaki; D G Eliopoulos; C Ponticoglou; G D Eliopoulos
Journal:  Int J Hematol       Date:  2001-04       Impact factor: 2.490

5.  Differentiation of benign monoclonal gammopathy and smouldering multiple myeloma from frank myeloma.

Authors:  K Shimizu; K Ohnishi; A Kunii
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.